Position
Squarepoint Ops LLC in Taysha Gene Therapies, Inc.
Back to the book · All holders of TSHA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$422.6K$5.50 → $4.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 471.6K | $2.59M | — | — | — | 0.0% |
| Q1 2026 | 410.3K | $1.83M | $4.47 | −$422.6K | −$337.1K | 0.0% |